LifeCell is a research-intensive premier biotech company driven by the power of medical science and innovation for 14 years. As an extension of our commitment towards the healthcare sector, LifeCell has expanded its newest division, Biologics. LifeCell Biologics focuses to cater a wide range of placental tissue derived therapeutic products to provide solutions to enhance patient life expectancy and reduce global disease burden.
We are dedicated towards pushing the boundaries of science to develop and deliver life-changing health care products to make a difference in the life of patients while reducing the average cost of healthcare. In addition to our current product AmchoPlast, LifeCell Biologics is expecting to launch a series of products derived from placental tissues which are presently under rigorous research and developmental pipeline.
Our research design and practices are fabricated to exceed the industry standard globally. A perfect blend of state-of-art research, extremely talented team and hi-tech manufacturing infrastructure have enabled us to stand alone as a well-recognized leading biotech company.
Amchoplast - A Biological Wound Cover
LifeCell Biologics introduces AmchoPlast - a minimally manipulated and aseptically processed dehydrated human amnion-chorion tissue allograft which restores wound bed physiology while supporting natural healing of chronic wounds.
LIFECELL INTERNATIONAL PVT. LTD.
#26, Vandalur Kelambakkam Main Road